CD36 and cancer: In fact, this basal B-specific splicing signature has highlighted a subpopulation of basal-like triple negative breast cancer patients differentially expressing several hallmarks of invasive, EMT-like aggressive cancer, such as the newly identified biomarker of metastasis CD36 [20].